Peroxisomal Disorders: Experience from a Genetic Center in North India

Suresh Kumar Angurana; Renu Suthar; Inusha Panigrahi

doi:10.1055/s-0038-1641581

Journal of Pediatric Neurology, Table of Contents

Journal of Pediatric Neurology 2019; 17(02): 065-070
DOI: 10.1055/s-0038-1641581

Original Article

Georg Thieme Verlag KG Stuttgart · New York

Peroxisomal Disorders: Experience from a Genetic Center in North India

Suresh Kumar Angurana

¹Department of Pediatrics, Advanced Pediatric Centre, Postgraduate Institute of Medical Education and Research, Chandigarh, India

,

Renu Suthar

¹Department of Pediatrics, Advanced Pediatric Centre, Postgraduate Institute of Medical Education and Research, Chandigarh, India

,

Inusha Panigrahi

²Genetics and Metabolic Unit, Department of Pediatrics, Advanced Pediatric Centre, Postgraduate Institute of Medical Education and Research, Chandigarh, India

› Author Affiliations

Abstract

Diagnosis of peroxisomal disorders (PDs) is often delayed because of unfamiliarity with the characteristic features of PDs and their genetic heterogeneity. Aim of this study was to describe clinical profiles of six children with PDs. This is a retrospective study involving six children with PDs. The patients included three males, one female, and a fetus. Three patients were diagnosed with Zellweger's syndrome, two with rhizomelic chondrodysplasia punctata, and one with X-linked adrenoleukodystrophy. These diagnoses were established based on clinical, radiological, and biochemical features (elevated very long chain fatty acids levels). Parents of all cases have been provided genetic counseling and advised of prenatal diagnosis. Diagnosis of PDs requires knowledge of characteristic clinicoradiological features, and clinical confirmation is possible with simple imaging and biochemical investigations. Molecular diagnosis is possible for selected cases.

Keywords

dysmorphism - peroxisomes - growth failure - epiphyseal stippling

Full Text

References

References
1 Waterham HR, Ebberink MS. Genetics and molecular basis of human peroxisome biogenesis disorders. Biochim Biophys Acta 2012; 1822 (09) 1430-1441
2 Steinberg SJ, Dodt G, Raymond GV, Braverman NE, Moser AB, Moser HW. Peroxisome biogenesis disorders. Biochim Biophys Acta 2006; 1763 (12) 1733-1748
3 Aubourg P, Wanders R. Peroxisomal disorders. Handb Clin Neurol 2013; 113: 1593-1609
4 Krause C, Rosewich H, Gärtner J. Rational diagnostic strategy for Zellweger syndrome spectrum patients. Eur J Hum Genet 2009; 17 (06) 741-748
5 Wanders RJ, Waterham HR. Peroxisomal disorders I: biochemistry and genetics of peroxisome biogenesis disorders. Clin Genet 2005; 67 (02) 107-133
6 Monte MJ, Alonso-Peña M, Briz O. , et al. ACOX2 deficiency: an inborn error of bile acid synthesis identified in an adolescent with persistent hypertransaminasemia. J Hepatol 2017; 66 (03) 581-588
7 Vilarinho S, Sari S, Mazzacuva F. , et al. ACOX2 deficiency: a disorder of bile acid synthesis with transaminase elevation, liver fibrosis, ataxia, and cognitive impairment. Proc Natl Acad Sci U S A 2016; 113 (40) 11289-11293
8 Phadke SR, Gupta N, Girisha KM. , et al. Rhizomelic chondrodysplasia punctata type 1: report of mutations in 3 children from India. J Appl Genet 2010; 51 (01) 107-110
9 Chhavi N, Prashanth S, Venkatesh C, Karthikeyan K. Rhizomelic chondrodysplasia punctata: a missed opportunity for early diagnosis. Indian J Hum Genet 2012; 18 (03) 344-345
10 Puri RD, Thakur S, Verma IC. Spectrum of severe skeletal dysplasias in North India. Indian J Pediatr 2007; 74 (11) 995-1002
11 Kulkarni ML, Pujar MS. Zellweger syndrome. Indian Pediatr 2003; 40 (07) 682
12 Kumar S, Suthar R, Sharda S, Panigrahi I, Marwaha RK. Zellweger syndrome: prenatal and postnatal growth failure with epiphyseal stippling. J Pediatr Endocrinol Metab 2014; 27 (1–2): 185-188
13 Lee PR, Raymond GV. Child neurology: Zellweger syndrome. Neurology 2013; 80 (20) e207-e210
14 Poznanski AK. Punctate epiphyses: a radiological sign not a disease. Pediatr Radiol 1994; 24 (06) 418-424 , 436
15 Poulos A, Sheffield L, Sharp P. , et al. Rhizomelic chondrodysplasia punctata: clinical, pathologic, and biochemical findings in two patients. J Pediatr 1988; 113 (04) 685-690
16 Bams-Mengerink AM, Majoie CB, Duran M. , et al. MRI of the brain and cervical spinal cord in rhizomelic chondrodysplasia punctata. Neurology 2006; 66 (06) 798-803 , discussion 789
17 Fujiki Y, Yagita Y, Matsuzaki T. Peroxisome biogenesis disorders: molecular basis for impaired peroxisomal membrane assembly: in metabolic functions and biogenesis of peroxisomes in health and disease. Biochim Biophys Acta 2012; 1822 (09) 1337-1342
18 Motley AM, Brites P, Gerez L. , et al. Mutational spectrum in the PEX7 gene and functional analysis of mutant alleles in 78 patients with rhizomelic chondrodysplasia punctata type 1. Am J Hum Genet 2002; 70 (03) 612-624
19 Moser HW, Mahmood A, Raymond GV. X-linked adrenoleukodystrophy. Nat Clin Pract Neurol 2007; 3 (03) 140-151
20 Noetzel MJ. Fish oil and myelin: cautious optimism for treatment of children with disorders of peroxisome biogenesis. Neurology 1998; 51 (01) 5-7
21 Maeda K, Kimura A, Yamato Y. , et al. Oral bile acid treatment in two Japanese patients with Zellweger syndrome. J Pediatr Gastroenterol Nutr 2002; 35 (02) 227-230